Log in

Relevant bibliographies by topics / NDDs / Books

To see the other types of publications on this topic, follow the link: NDDs.

Books on the topic 'NDDs'

Author: Grafiati

Published: 30 June 2021

Last updated: 29 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'NDDs.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Society, National Deaf Children's, ed. NDCS technology services. NDCS, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Minaev, B. A. NDS: Aktualʹnye voprosy. Glavbukh, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hughes, Jeffrey F. NDS for NT. IDG Books Worldwide, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

National Disaster Medical System (U.S.), ed. NDMS, catastrophic care for the nation. National Disaster Medical System, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Luis, Hernández Otero Ricardo, ed. NDCS, nuevo diccionario cubano de seudónimos. Rogés Llibres, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Jeffrey, Harris, ed. Administering NDS corporate edition. McGraw-Hill, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ukraine. NDS: Sbornik sistematizirovannogo zakonodatelʹstva. "Faktor", 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Andrew, Chris. Novell's NDS developer's guide. Novell Press, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

(Canada), NDSS Steering Committee. National Diabetes Surveillance System (NDSS) business plan. 3rd ed. Health Canada, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Konstantinov, V. N. Ischislenie NDS predprii͡a︡tii͡a︡mi razlichnykh otrasleĭ. Glavbukh, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Seleznev, A. P. Spravochnik platelʹshchika NDS: Zakonodatelʹnye terminy i opredelenii︠a︡, sistematizirovannyĭ ukazatelʹ osnovnykh polozheniĭ NDS, GNAU razʺi︠a︡sni︠a︡et, obzor konfliktnykh situat︠s︡iĭ, NDS i nalog na pribylʹ. "Prapor", 1998., 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Chatterjee, M. NDDP multi-stage flash desalination process simulator design. Bhabha Atomic Research Centre, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Society, National Deaf Children's. Welcome to NDCS the National Deaf Children's Society. NDCS, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Services, Canada National Dosimetry. Technology comparison, NDS-National Dosimetry Services. Health Canada, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Hughes, Jeffrey F. Novell's four principles of NDS design. Novell Press, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

TVGAME360, ed. NDS/NDSL wu suo bu wan. Qi biao chu ban gu fen you xian gong si, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Ltd, Kaif Informatics, and National Library of Canada, eds. Network directory service: NDS service definition. s.n., 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Stafford, Bruce. New Deal for Disabled People (NDDP): First synthesis report. Department for Work and Pensions Research Management, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Association, American Forest &. Paper. NDS, national design specification for wood construction. The Association, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Alexander, Milson, and Tofield Christopher, eds. Ha nds-on guide to clinical pharmacology. Blackwell Science, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

N, Sashi Kumar G., and Bhabha Atomic Research Centre, eds. NDDP multi-stage flash desalination process simulator design "process optimization". Bhabha Atomic Research Centre, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Schweiger, Detlef. Sa[e]nds: Malerei Collage Zeichnung Grafik, 1995-1997. Artco, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Makhrov, I. E. NDS po ėksportu: Vozmeshchenie iz bi︠u︡dzheta : kommentariĭ k zakonodatelʹstvu. I︠U︡stit︠s︡inform, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Cummings, Jeffrey L., and Jagan A. Pillai. Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0001.

Full text

Abstract:

Neurodegenerative diseases (NDDs) are growing in frequency and represent a major threat to public health. Advances in scientific progress have made it clear that NDDs share many underlying processes, including shared intracellular mechanisms such as protein misfolding and aggregation, cell-to-cell prion-like spread, growth factor signaling abnormalities, RNA and DNA disturbances, glial cell changes, and neuronal loss. Transmitter deficits are shared across many types of disorders. Means of studying NDDs with human iPS cells and transgenic models are similar. The progression of NDDs through asy

APA, Harvard, Vancouver, ISO, and other styles

25

Jay, Taylor R., Shane M. Bemiller, Lee E. Neilson, Paul J. Cheng-Hathaway, and Bruce T. Lamb. Neuroinflammation and Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0004.

Full text

Abstract:

Neuroinflammation has long been associated with many neurodegenerative diseases (NDDs). Immune-related genetic and environmental risk factors have recently been identified for NDDs, suggesting that neuroinflammation can play an active role in modifying NDD pathologies. Immune cells that underlie this neuroinflammatory response can have both beneficial and detrimental roles in NDDs. These cells can engage in clearance of debris and provide important survival factors to neighboring neurons. However, these cells can also release inflammatory molecules that promote oxidative stress and excitotoxic

APA, Harvard, Vancouver, ISO, and other styles

26

Cummings, Jeffrey L., and Kate Zhong. Clinical Trials and Drug Development in Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0018.

Full text

Abstract:

This chapter describes the common therapeutic targets, approaches to clinical trial design, biomarkers, and therapeutic interventions across neurodegenerative disorders (NDDs). Each unique NDD-Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), etc.-has a unique phenotype associated with the regional cell population most affected. Each disease, however, is associated with protein misfolding, oxidation, inflammation, apoptosis, and cell death. If vulnerable cell populations include transmitter source nuclei, transmitter deficits also emerge (e.g. cholinergic

APA, Harvard, Vancouver, ISO, and other styles

27

Pillai, Jagan A., and Jeffrey L. Cummings. Conclusions on Neurodegenerative Disorders. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0019.

Full text

Abstract:

Neurodegenerative diseases strip an individual of his or her cognitive powers, functional capacity, and autonomy while increasing dependence on others. They are an existential threat to an aging society in its ability to provide a meaningful and high quality of life to all its citizens. The classical view of neurodegenerative disorders (NDDs) emphasized the distinctness of each NDD ,with a definable clinical syndrome of neurological deficits, behavioral changes, and progressive functional decline, underpinned by inexorable neuronal loss that is pathological for the age of the subject. Neurodeg

APA, Harvard, Vancouver, ISO, and other styles

28

Pillai, Jagan A. Predementia Disorders. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0009.

Full text

Abstract:

Neurodegenerative disorders (NDDs) are currently conceptualized as proteinopathies with a long trajectory of pathological changes preceding the onset of clinical symptoms by over a decade. Predementia, the stage of disease before onset of clinical symptoms and dementia where significant irreversible neuronal damage and cognitive decline have yet to occur, is seen as a promising stage to target for a new generation of therapeutic interventions. This chapter reviews the growing understanding of the predementia stages across NDDs and some of the developing challenges to the present clinical chara

APA, Harvard, Vancouver, ISO, and other styles

29

Bekris, Lynn M., and James B. Leverenz. Genetics of Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0010.

Full text

Abstract:

A great deal has been discovered about Neurodegenerative disorders (NDDs) including Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, dementia with Lewy bodies . This includes genetic variants associated with both sporadic and autosomal dominant NDDs. These findings have been crucial in our understanding the underlying factors that drive neuropathological changes and in clarifying the time line of biomarker changes in presymptomatic autosomal dominant mutation carriers. While much is still to be learned, these findings will play an important role in the future of neurodegenera

APA, Harvard, Vancouver, ISO, and other styles

30

Padilla, Claudia R., and Mario F. Mendez. Neuropsychiatric Features Across Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0006.

Full text

Abstract:

Neuropsychiatric symptoms (NPS) are a major manifestation of neurodegenerative diseases(NDDs) including Alzheimer’s disease (AD), Dementia with Lewy Bodies (DLB) and frontotemporal dementia (FTD). NPS symptoms are a determining factor impacting economic and psychological costs for both the patient and their caregivers in these devastating illness. Recent developments in neuroscience have clarified the relationship of NPS with changes in brain structures, alterations in neural circuits and networks, and their neurotransmitter systems. It is increasingly recognized that NPS shared across differe

APA, Harvard, Vancouver, ISO, and other styles

31

Drouin-Ouellet, Janelle, and Roger A. Barker. Disease-Modifying Therapies in Neurodegenerative Disorders. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0016.

Full text

Abstract:

The recent identification of the genetic basis of many neurodegenerative disorders (NDDs), coupled with a greater understanding of their pathophysiology, has enabled better therapeutic strategies to be identified and tried. This includes approaches that target critical specific nodes in the disease pathways, for example, agents that modulate levels of mutant huntingtin in Huntington’s disease. In addition to these highly specific targeted therapies, there is also a growing realization that more generic lifestyle therapies influencing whole brain health may also have merit in treating these con

APA, Harvard, Vancouver, ISO, and other styles

32

Nakamura, Tomohiro, and Stuart A. Lipton. Neurodegenerative Diseases as Protein Misfolding Disorders. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0002.

Full text

Abstract:

Neurodegenerative diseases (NDDs) often represent disorders of protein folding. Rather than large aggregates, recent evidence suggests that soluble oligomers of misfolded proteins are the most neurotoxic species. Emerging evidence points to small, soluble oligomers of misfolded proteins as the cause of synaptic dysfunction and loss, the major pathological correlate to disease progression in many NDDs including Alzheimer’s disease. The protein quality control machinery of the cell, which includes molecular chaperones as found in the endoplasmic reticulum (ER), the ubiquitin-proteasome system (U

APA, Harvard, Vancouver, ISO, and other styles

33

Zetterberg, Henrik, and Jonathan M. Schott. Fluid Biomarkers Indicative of Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0008.

Full text

Abstract:

A major unifying feature of neurodegenerative diseases (NDDs) is excessive neuronal loss. Depending on when and where this occurs, patients may express distinct neurological and psychiatric symptoms. Neurodegeneration is accompanied by protein aggregation, inflammation, and microglial activation that may be drivers of the disease or in some circumstances may be protective reactions to the neurodegenerative process. A key development over the past decade has been our ability to leverage these accompanying central nervous system changes to develop clinically impactful biomarkers of specific NDDs

APA, Harvard, Vancouver, ISO, and other styles

34

Nat, Roxana, and Andreas Eigentler. Cell Culture, iPS Cells and Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0013.

Full text

Abstract:

Somatic reprogramming technology, which enables the conversion of adult human non-neural cells into neurons, has progressed rapidly in recent years. The derivation of patient-specific induced pluripotent stem (iPS) cells has become routine. The inherent broad differentiation potential of iPS cells makes possible the generation of diverse types of human neurons. This constitutes a remarkable step in facilitating the development of more appropriate and comprehensive preclinical human disease models, as well as for high throughput drug screenings and cell therapy. This chapter reviews recent prog

APA, Harvard, Vancouver, ISO, and other styles

35

Holzmann, Robert. The ABCs of NDCs. World Bank, Washington, DC, 2019. http://dx.doi.org/10.1596/31627.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Vern, Jules. CÆsar Cascabel: NDAS Digest. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Martin, Doc. NDEs ETs and PTSD. Lulu Press, Inc., 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Homer, Blaine. Netware Printing: Managing Ndps. New Riders Pub, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Homer, Blaine. Netware Printing With Ndps. New Riders Pub, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Belikova, T. N. Vse ob NDS. Piter, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Vern, Jules. Meridiana: Ndas Digest Print Edition. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Persuasion: Ndas Digest Print Edition. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Mazzucato, Mariana, and Caetano C. R. Penna. National Development Banks and Mission-Oriented Finance for Innovation. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780198827948.003.0010.

Full text

Abstract:

How can one conceptualize the new ‘mission-oriented’ role assumed by national development banks (NDBs)? The standard ‘market failure’ perspective provides only a partial and limited justification for what NDBs do and does not explain historical and contemporary developments. This chapter combines insights from Keynes, Minsky, Schumpeter, and Polanyi (and works in their tradition) to review the old and new roles of NDBs. It discusses these roles taking into account two important dimensions: (i) the relationship between risks and rewards, and (ii) the criticisms that NDBs crowd out private inves

APA, Harvard, Vancouver, ISO, and other styles

44

Vern, Jules. Godfrey Morgan: Ndas Digest Print Edition. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Vern, Jules. Fur Country: Ndas Digest Print Edition. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Vern, Jules. Floating City: Ndas Digest Print Edition. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Vern, Jules. Antarctic Mystery: Ndas Digest Print Edition. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Vern, Jules. Green Ray: Ndas Digest Print Edition. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Vern, Jules. Mathias Sandorf: Ndas Digest Print Edition. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

Vern, Jules. Claudius Bombarnac: Ndas Digest Print Edition. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!